Thus, further prospective studies are needed to establish whether increased OPG/RANKL levels and/or CIMT in diabetic patients can in fact predict later development of endothelial dysfunction and vascular complications. The gene discussed is TNFRSF11B; the disease is endothelial dysfunction.